Nathaniel E. David

Nathaniel E. David has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Kythera Biopharmaceuticals Inc and Unity Biotechnology, Inc. The record holds 59 filings, for trades running from 16 October 2012 to 16 December 2020.

On the open market, the record shows 1 purchase worth €25k and 50 sales worth €10.2M. The net balance comes to €10.1M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants. In 2020 alone, the filings show 1 purchase and 1 sale.

The newest entry dates from 18 December 2020: an open-market sale of €7.3M, in Unity Biotechnology, Inc. The last insider purchase was made public on 9 June 2020, 2,327 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.